5-Amino-2,4,6- triiodisophthaloyl acid dichloride(ATIPA) Cas 37441-29-5
Assay (HPLC): 98%min
Package Size: 25kg/drum
Sample: Available
Capacity: 200MT/year
related documents:
COA of 5-Amino-2,4,6- triiodisophthaloyl acid dichloride(ATIPA) Cas 37441-29-5
TDS of 5-Amino-2,4,6- triiodisophthaloyl acid dichloride(ATIPA) Cas 37441-29-5
HPLC of 5-Amino-2,4,6- triiodisophthaloyl acid dichloride(ATIPA) Cas 37441-29-5
Request for product documents
Product Overview: 5-Amino-2,4,6-Triiodisophthaloyl Acid Dichloride (ATIPA)
Table of Contents
1. Basic Information & Specifications
| Parameter | Value |
|---|---|
| CAS Number | 37441-29-5 |
| Molecular Formula | C8H2Cl2I3NO2 |
| Molecular Weight | 595.73 g/mol |
| IUPAC Name | 5-Amino-2,4,6-triiodoisophthaloyl dichloride |
| Appearance | Off-white to light yellow crystalline powder |
| Storage Conditions | 2-8°C in airtight container, protected from light |
2. Key Applications & Industrial Uses
ATIPA serves as a critical intermediate in:
- X-ray Contrast Media: Core component in iodinated contrast agents for medical imaging
- Pharmaceutical Synthesis: Building block for thyroid medications and diagnostic compounds
- Polymer Chemistry: Cross-linking agent for specialty resins and high-performance materials
- Research Applications: Probe molecule in biochemical studies requiring heavy atom markers
3. Performance Comparison
| Parameter | ATIPA | Conventional Iodinated Compounds |
|---|---|---|
| Iodine Content | 63.9% | 45-55% |
| Thermal Stability | Stable up to 150°C | Decomposes above 100°C |
| Solubility Profile | Compatible with polar aprotic solvents | Limited solvent compatibility |
4. Case Studies
Medical Imaging Enhancement
A leading contrast agent manufacturer achieved 30% improvement in image resolution by incorporating ATIPA-derived compounds in their next-generation CT contrast media.
Specialty Polymer Development
ATIPA-enabled cross-linked polymers demonstrated 40% higher radiation resistance in aerospace material testing compared to traditional formulations.
5. Client Success Stories
Case 1: European Pharma Leader
- Challenge: Needed stable iodinated intermediate for long-acting thyroid medication
- Solution: Custom ATIPA synthesis with >99.5% purity
- Outcome: 18-month stability improvement in final formulation
Case 2: Asian Research Consortium
- Challenge: Required heavy atom marker for protein crystallography
- Solution: ATIPA derivatives with site-specific labeling
- Outcome: Successful determination of 3D protein structures at 1.8Å resolution
6. Contact for Customized Solutions
Optimize your formulations with our technical expertise:
- Email: info@vivalr.com
- Phone: (86) 15866781826
Request custom synthesis specifications or application support within 24 hours.



评论
目前还没有评论。